Opendata, web and dolomites

MetD-AO SIGNED

Methyl Donating artificial organelles to support liver cells in Non-alcoholic fatty liver disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MetD-AO project word cloud

Explore the words cloud of the MetD-AO project. It provides you a very rough idea of what is the project "MetD-AO" about.

lost    donating    liver    expertise    intact    metd    preserving    latter    function    employing    structurally    amphiphilic    chemist    biocatalytic    dr    chronic    intracellular    oxygen    prospects    enzyme    tail    synth    medical    nonalcoholic    conduction    encapsulated    vitro    encompassing    organelles    single    aos    failing    nano    western    cytosol    characterization    reactive    spectrum    damage    disease    self    deficiencies    organic    hydrophilic    biology    colloidal    started    nanoparticles    ao    gaining    multiple    lysosome    methyl    destroyed    poly    me    lysosomal    cell    trained    adenosylmethionine    prior    methacrylate    world    perform    missing    few    protein    carrier    successful    therapeutic    complementary    copolymers    nafld    outcome    career    sized    escape    respectively    homeostasis    assemble    substitute    science    reactors    stadler    pharmaceutical    polymer    membranolytic    biosynthesis    functional    fatty    reaction    consisting    release    assembly    synthetase    carboxypentyl    cargo    cholesterol    host    hepatocytes    acrylate    reported    mimicking    artificial    compartment    cellular    entirely   

Project "MetD-AO" data sheet

The following table provides information about the project.

Coordinator
AARHUS UNIVERSITET 

Organization address
address: NORDRE RINGGADE 1
city: AARHUS C
postcode: 8000
website: www.au.dk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 219˙312 €
 EC max contribution 219˙312 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2018
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2021-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    AARHUS UNIVERSITET DK (AARHUS C) coordinator 219˙312.00

Map

 Project objective

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world, encompassing a spectrum of liver damage. Multiple issues are involved on the cellular level in failing liver often including enzyme deficiencies such as reduced biosynthesis of S-adenosylmethionine (SAMe). Preserving SAMe homeostasis has only recently started to be considered as a potential therapeutic target in liver-related medical conditions. However, employing the required enzyme, SAMe synthetase (SAMe-synth), as a pharmaceutical, is challenging due to the general issues involved in intact (functional) protein delivery. The aim of the MetD-AO project is to assemble organic SAMe-synth activity mimicking polymer nanoparticles as artificial organelles (AO) and their in vitro characterization of intracellular function in hepatocytes. AOs are typically nano-sized single compartment reactors, aimed to perform a specific encapsulated biocatalytic reaction within a cell to substitute for missing or lost function. The AO will be based on amphiphilic copolymers consisting of a methyl-donating unit, cholesterol methacrylate and poly(5-carboxypentyl acrylate) as membranolytic hydrophilic tail. The latter two will aim at facilitating self-assembly and lysosomal escape, respectively. To allow structurally intact AO to escape the lysosome is unique since typically, the carrier is destroyed and only the therapeutic cargo is release into the cytosol. The proposed AOs with methyl-donating ability are highly advanced because the few prior reported AOs with intracellular activity all considered reactive oxygen related aspects at best. The successful outcome of MetD-AO has the potential to open up entirely new therapeutic opportunities in NAFLD. The complementary expertise of my host Dr. Stadler and me, a trained polymer chemist, will ensure a successful conduction of MetD-AO while it will enhance my future career prospects gaining experience in colloidal science and cell biology.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "METD-AO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "METD-AO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

RipGEESE (2020)

Identifying the ripples of gene regulation evolution in the evolution of gene sequences to determine when animal nervous systems evolved

Read More  

MacMeninges (2019)

Control of Central Nervous Sytem inflammation by meningeal macrophages, and its impairment upon aging

Read More  

DEF2DEV (2019)

Identification of the mode of action of plant defensins during root development and plant defense responses.

Read More